NCT06468956
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
Registry fields
- Overall status
- COMPLETED
- Conditions
- Moderate to Severe Atopic Dermatitis
- Study type
- INTERVENTIONAL
- Phase
- PHASE3
- Primary purpose
- TREATMENT
- Intervention type
- DRUG
- Interventions
- SHR-1819, Placebo
- Lead sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd (INDUSTRY)
Cached at: 2026-09-04 00:16:45
Brief summary
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with atopic dermatitis.
Contact
Need a report or Korean medical writing based on this trial?
Sign in with Kakao to continue